- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.06. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| QT IMAGING Aktie jetzt für 0€ handeln | |||||
| 13.05. | QT Imaging Holdings GAAP EPS of -$0.40, revenue of $2.8M | 1 | Seeking Alpha | ||
| 13.05. | QT Imaging announces $200,000 PIPE investment | 2 | Seeking Alpha | ||
| 13.05. | QT IMAGING HOLDINGS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 23.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.04. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.03. | QT Imaging Holdings GAAP EPS of -$0.15 | 1 | Seeking Alpha | ||
| 31.03. | QT IMAGING HOLDINGS, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 31.03. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 28.02. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 27.02. | QT Imaging receives $10.1M in new funding | 1 | Seeking Alpha | ||
| 12.02. | QT IMAGING HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 05.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.02.2025 | 931 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.02.2025ISIN NameCA75525M1095 RAZOR... ► Artikel lesen | |
| 31.01. | QT IMAGING HOLDINGS, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 24.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 16.01. | QT Imaging files to sell 8.81M shares of common stock for holders | 1 | Seeking Alpha | ||
| 16.01. | QT IMAGING HOLDINGS, INC. - S-1, General form for registration of securities | - | SEC Filings | ||
| 13.01. | QT Imaging sichert finanzielle Grundlage und prognostiziert Wachstum | 1 | Investing.com Deutsch |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 443,00 | +0,18 % | P/E Ratio Insights for Intuitive Surgical | ||
| SERNOVA BIOTHERAPEUTICS | 0,106 | +2,91 % | Research Capital analyst Andre Uddin keeps "Speculative Buy" rating on Sernova Biotherapeutics | ||
| ATOSSA THERAPEUTICS | 0,705 | +2,77 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,846 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,006 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,232 | +0,87 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,521 | -1,23 % | Veru Inc.: Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide ... | --Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial... ► Artikel lesen | |
| CYTOSORBENTS | 1,036 | +0,19 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,798 | +13,15 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 2,880 | -21,74 % | Ekso Bionics Stock Dips 4% Despite AI Integration Milestone | ||
| IMUNON | 0,870 | -1,69 % | Imunon, Inc.: IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025 | ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism... ► Artikel lesen | |
| BEYOND AIR | 0,202 | +2,54 % | Beyond Air Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update | Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| NOVACYT | 0,492 | -1,30 % | Novacyt S.A. - Result of AGM |
Das Unternehmen QT IMAGING HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,37 % bei einem Aktienkurs von 0,401 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QT IMAGING HOLDINGS INC finden Sie auf Wallstreet Online.